Back
Halozyme Therapeutics Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
30
HALO
Halozyme Therapeutics
Last Price:
51.65
Seasonality Move:
20.13%
Sell
30
HALO
Halozyme Therapeutics
Last Price:
51.65
Seasonality Move:
20.13%
Sell
30
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $50.65. The Score for HALO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $50.65. The Score for HALO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $50.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $50.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 30.8 | Sell |
| Chaikin Money Flow: | -1825954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.62 - 61.32) | Sell |
| Bollinger Bands (100): | (49 - 60.08) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 30.8 | Sell |
| Chaikin Money Flow: | -1825954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.62 - 61.32) | Sell |
| Bollinger Bands (100): | (49 - 60.08) | Sell |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.28 | Sell |
| 20-day SMA: | 58.18 | Sell |
| 50-day SMA: | 58.64 | Sell |
| 200-day SMA: | 46.49 | Buy |
| 8-day EMA: | 55.36 | Sell |
| 20-day EMA: | 57.29 | Sell |
| 50-day EMA: | 57.37 | Sell |
| 200-day EMA: | 49.67 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.28 | Sell |
| 20-day SMA: | 58.18 | Sell |
| 50-day SMA: | 58.64 | Sell |
| 200-day SMA: | 46.49 | Buy |
| 8-day EMA: | 55.36 | Sell |
| 20-day EMA: | 57.29 | Sell |
| 50-day EMA: | 57.37 | Sell |
| 200-day EMA: | 49.67 | Buy |
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.79 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.79 per share.
Halozyme Therapeutics Technical Analysis
| Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||